ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $64,237,703,000 | +88.8% | 1,386,525 | -0.6% | 0.05% | +84.0% |
| Q1 2019 | $34,021,290,000 | +41.9% | 1,395,459 | -17.1% | 0.02% | +19.0% |
| Q4 2018 | $23,978,333,000 | +1.3% | 1,682,690 | +8.1% | 0.02% | +16.7% |
| Q3 2018 | $23,669,334,000 | -13.3% | 1,557,193 | -4.3% | 0.02% | -14.3% |
| Q2 2018 | $27,290,137,000 | -15.9% | 1,626,349 | -18.2% | 0.02% | -19.2% |
| Q1 2018 | $32,462,389,000 | +20.1% | 1,989,117 | -5.8% | 0.03% | +13.0% |
| Q4 2017 | $27,039,207,000 | +184.0% | 2,112,438 | +172.9% | 0.02% | +155.6% |
| Q3 2017 | $9,520,951,000 | +44.2% | 774,061 | -1.9% | 0.01% | +50.0% |
| Q2 2017 | $6,603,863,000 | -9.2% | 788,992 | -3.0% | 0.01% | -14.3% |
| Q1 2017 | $7,273,870,000 | +96859.1% | 813,632 | -4.7% | 0.01% | -12.5% |
| Q4 2016 | $7,502,000 | +1251.7% | 853,469 | +937.3% | 0.01% | +700.0% |
| Q3 2016 | $555,000 | +89.4% | 82,280 | 0.0% | 0.00% | – |
| Q2 2016 | $293,000 | +21.1% | 82,280 | 0.0% | 0.00% | – |
| Q1 2016 | $242,000 | -44.5% | 82,280 | -20.3% | 0.00% | – |
| Q4 2015 | $436,000 | -1.8% | 103,278 | +6.2% | 0.00% | – |
| Q3 2015 | $444,000 | -28.8% | 97,278 | +12.5% | 0.00% | -100.0% |
| Q2 2015 | $624,000 | +43.1% | 86,478 | +46.3% | 0.00% | – |
| Q1 2015 | $436,000 | +80.9% | 59,096 | +16.1% | 0.00% | – |
| Q4 2014 | $241,000 | +32.4% | 50,896 | 0.0% | 0.00% | – |
| Q3 2014 | $182,000 | -21.6% | 50,896 | 0.0% | 0.00% | – |
| Q2 2014 | $232,000 | -2.9% | 50,896 | 0.0% | 0.00% | – |
| Q1 2014 | $239,000 | -6.3% | 50,896 | 0.0% | 0.00% | – |
| Q4 2013 | $255,000 | -40.7% | 50,896 | -26.2% | 0.00% | -100.0% |
| Q3 2013 | $430,000 | +37.4% | 68,996 | 0.0% | 0.00% | – |
| Q2 2013 | $313,000 | – | 68,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |